Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionadenosine-phosphate deaminase activity

AMPD2 AMPD3

2.75e-053612GO:0047623
GeneOntologyMolecularFunctionAMP deaminase activity

AMPD2 AMPD3

2.75e-053612GO:0003876
GeneOntologyMolecularFunctionvoltage-gated chloride channel activity

CLCNKA CLCNKB

4.96e-0411612GO:0005247
DomainCl_channel-K

CLCNKA CLCNKB

1.05e-052612IPR002250
DomainAMPD

AMPD2 AMPD3

3.14e-053612IPR006329
DomainA/AMP_deam_AS

AMPD2 AMPD3

6.27e-054612IPR006650
DomainA_deaminase

AMPD2 AMPD3

1.56e-046612PF00962
DomainA_DEAMINASE

AMPD2 AMPD3

1.56e-046612PS00485
DomainA/AMP_deaminase_dom

AMPD2 AMPD3

1.56e-046612IPR001365
DomainCl-channel_core

CLCNKA CLCNKB

3.72e-049612IPR014743
Domain-

CLCNKA CLCNKB

3.72e-0496121.10.3080.10
DomainVoltage_CLC

CLCNKA CLCNKB

3.72e-049612PF00654
DomainCl-channel_volt-gated

CLCNKA CLCNKB

3.72e-049612IPR001807
DomainPDZ

MAGI2 MAST4 APBA3 SCRIB

1.16e-03141614PF00595
DomainCBS

CLCNKA CLCNKB

1.22e-0316612SM00116
DomainPDZ

MAGI2 MAST4 APBA3 SCRIB

1.39e-03148614SM00228
Domain-

MAGI2 MAST4 APBA3 SCRIB

1.46e-031506142.30.42.10
DomainPDZ

MAGI2 MAST4 APBA3 SCRIB

1.50e-03151614PS50106
DomainPDZ

MAGI2 MAST4 APBA3 SCRIB

1.54e-03152614IPR001478
DomainCBS_dom

CLCNKA CLCNKB

1.92e-0320612IPR000644
DomainCBS

CLCNKA CLCNKB

1.92e-0320612PF00571
DomainCBS

CLCNKA CLCNKB

1.92e-0320612PS51371
DomainIG

SIGLEC9 OSCAR SDK1 LILRA5 IGDCC4 PTK7

2.47e-03421616SM00409
DomainIg_sub

SIGLEC9 OSCAR SDK1 LILRA5 IGDCC4 PTK7

2.47e-03421616IPR003599
DomainMetal_Hydrolase

AMPD2 AMPD3

2.77e-0324612IPR032466
DomainIg-like_dom

SIGLEC9 OSCAR SDK1 LILRA5 IGDCC4 PTK7

5.88e-03503616IPR007110
DomainFHA_dom

PNKP CHEK2

6.15e-0336612IPR000253
Domain-

PNKP CHEK2

6.15e-03366122.60.200.20
DomainIGc2

SDK1 LILRA5 IGDCC4 PTK7

7.28e-03235614SM00408
DomainIg_sub2

SDK1 LILRA5 IGDCC4 PTK7

7.28e-03235614IPR003598
DomainPTB

APBA3 EPS8L1

7.56e-0340612SM00462
DomainPTB/PI_dom

APBA3 EPS8L1

7.93e-0341612IPR006020
Pubmed

Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney.

CLCNKA CLCNKB

3.77e-0626828544406
Pubmed

AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder.

AMPD2 AMPD3

3.77e-06268223911318
Pubmed

The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron.

CLCNKA CLCNKB

3.77e-06268227335120
Pubmed

Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization.

CLCNKA CLCNKB

3.77e-0626828812470
Pubmed

Associations between CLCNKA_B tag SNPs with essential hypertension and interactions between genetic and environmental factors in an island population in China.

CLCNKA CLCNKB

3.77e-06268225919862
Pubmed

Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes.

CLCNKA CLCNKB

3.77e-06268224863058
Pubmed

Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel.

CLCNKA CLCNKB

3.77e-0626829916798
Pubmed

Kidney kinetics and chloride ion pumps.

CLCNKA CLCNKB

3.77e-0626829916791
Pubmed

Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss.

CLCNKA CLCNKB

3.77e-06268238069401
Pubmed

A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels.

CLCNKA CLCNKB

3.77e-06268220805576
Pubmed

AMP deaminase 3 plays a critical role in remote reperfusion lung injury.

AMPD2 AMPD3

3.77e-06268223542464
Pubmed

Salt wasting and deafness resulting from mutations in two chloride channels.

CLCNKA CLCNKB

3.77e-06268215044642
Pubmed

Two highly homologous members of the ClC chloride channel family in both rat and human kidney.

CLCNKA CLCNKB

3.77e-0626828041726
Pubmed

A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane.

CLCNKA CLCNKB

3.77e-06268218648499
Pubmed

Cl(-) channels in basolateral TAL membranes XV. Molecular heterogeneity between cortical and medullary channels.

CLCNKA CLCNKB

3.77e-06268211014860
Pubmed

Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional.

CLCNKA CLCNKB

1.13e-05368226013830
Pubmed

Barttin increases surface expression and changes current properties of ClC-K channels.

CLCNKA CLCNKB

1.13e-05368212111250
Pubmed

Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons.

AMPD2 AMPD3

1.13e-0536821400401
Pubmed

Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension.

CLCNKA CLCNKB

1.13e-05368217510212
Pubmed

Platelet AMP deaminase. Purification and kinetic studies.

AMPD2 AMPD3

1.13e-0536827287721
Pubmed

Protein tyrosine kinase 7 has a conserved role in Wnt/β-catenin canonical signalling.

SCRIB PTK7

1.13e-05368221132015
Pubmed

Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms.

AMPD2 AMPD3

1.13e-0536829857047
Pubmed

Barttin is a Cl- channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion.

CLCNKA CLCNKB

1.13e-05368211734858
Pubmed

Barttin modulates trafficking and function of ClC-K channels.

CLCNKA CLCNKB

1.13e-05368216849430
Pubmed

Molecular cloning of AMP deaminase isoform L. Sequence and bacterial expression of human AMPD2 cDNA.

AMPD2 AMPD3

1.13e-0536821429593
Pubmed

Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance.

CLCNKA CLCNKB

1.13e-05368218094726
Pubmed

Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Krüppel-like factor, a novel zinc finger repressor.

CLCNKA CLCNKB

1.13e-05368210982849
Pubmed

Cdx mediates neural tube closure through transcriptional regulation of the planar cell polarity gene Ptk7.

SCRIB PTK7

2.25e-05468221350009
Pubmed

Haplotype diversity in four genes (CLCNKA, CLCNKB, BSND, NEDD4L) involved in renal salt reabsorption.

CLCNKA CLCNKB

2.25e-05468217652939
Pubmed

BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype.

CHEK2 FANCA

3.75e-05568237549632
Pubmed

Characterization of the murine orthologue of a novel human subtelomeric multigene family.

WASH6P WASH4P

3.75e-05568211701968
Pubmed

Human subtelomeric WASH genes encode a new subclass of the WASP family.

WASH6P WASH4P

5.62e-05668218159949
Pubmed

Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage.

AMPD2 AMPD3

5.62e-05668229079593
Pubmed

Epidermal wound repair is regulated by the planar cell polarity signaling pathway.

SCRIB PTK7

5.62e-05668220643356
Pubmed

Impairment in renal medulla development underlies salt wasting in Clc-k2 channel deficiency.

CLCNKA CLCNKB

7.86e-05768234499620
Pubmed

Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney.

CLCNKA CLCNKB

7.86e-05768211423561
Pubmed

Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.

TBXAS1 MAGI2

1.05e-04868223007406
Pubmed

Planar cell polarity pathway regulates actin rearrangement, cell shape, motility, and nephrin distribution in podocytes.

MAGI2 SCRIB

1.34e-04968220534871
Pubmed

Changing expression of chloride channels during preimplantation mouse development.

CLCNKA CLCNKB

1.34e-04968223115349
Pubmed

The novel mouse mutant, chuzhoi, has disruption of Ptk7 protein and exhibits defects in neural tube, heart and lung development and abnormal planar cell polarity in the ear.

SCRIB PTK7

1.34e-04968220704721
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MAGI2 FAF2 SYNE1 SCRIB FHIP2A IGDCC4

1.47e-0440768612693553
Pubmed

DSCAM regulates delamination of neurons in the developing midbrain.

MAGI2 MAPK8

2.05e-041168232917586
Pubmed

Wnt activity guides facial branchiomotor neuron migration, and involves the PCP pathway and JNK and ROCK kinases.

SCRIB MAPK8

2.05e-041168219210786
Pubmed

Regulation of Chk2 phosphorylation by interaction with protein phosphatase 2A via its B' regulatory subunit.

PPP2R5B CHEK2

2.45e-041268215380617
Pubmed

Planar cell polarity defects and defective Vangl2 trafficking in mutants for the COPII gene Sec24b.

SCRIB PTK7

2.45e-041268220215345
Pubmed

Convergent extension, planar-cell-polarity signalling and initiation of mouse neural tube closure.

SCRIB MAPK8

2.90e-041368217229766
Pubmed

PTK7 regulates myosin II activity to orient planar polarity in the mammalian auditory epithelium.

MAPK8 PTK7

3.38e-041468222560610
Pubmed

A genome-wide association study of optic disc parameters.

CHEK2 SCYL1

3.38e-041468220548946
Pubmed

Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.

KMT2D CHEK2 SMO

3.71e-047168328319113
Pubmed

Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.

PNKP FAF2 AP3B2 SCYL1 SCRIB EPB41

4.32e-0449868636634849
Pubmed

AP-SWATH Reveals Direct Involvement of VCP/p97 in Integrated Stress Response Signaling Through Facilitating CReP/PPP1R15B Degradation.

FAF2 CHEK2 EPS8L1

4.54e-047668329599191
Pubmed

Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption.

PROX2 FANCA

5.03e-041768221490707
Pubmed

SHROOM3 is downstream of the planar cell polarity pathway and loss-of-function results in congenital heart defects.

SCRIB MAPK8

7.00e-042068232511952
Pubmed

Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.

CHEK2 MAPK8 FANCA

7.20e-048968318950845
Pubmed

Primary cilia in murine palatal rugae development.

SMO MAPK8

9.28e-042368231226309
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

FOXJ2 KANSL3 PNKP KMT2D CHEK2 SCRIB LACTB

1.42e-0385768725609649
Pubmed

Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.

TBXAS1 FBXO10 CHEK2

1.59e-0311768319124506
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

WASH6P ANGEL1 SCRIB FHIP2A PTK7 FANCA

1.71e-0365068638777146
Pubmed

Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.

CHEK2 FANCA

1.91e-033368219714462
GeneFamilyAdenosine deaminase family

AMPD2 AMPD3

9.44e-0564621302
GeneFamilyChloride voltage-gated channels

CLCNKA CLCNKB

2.81e-0410462302
GeneFamilyPDZ domain containing

MAGI2 MAST4 APBA3 SCRIB

5.95e-041524641220
GeneFamilyWiskott-Aldrich Syndrome protein family

WASH6P WASH4P

7.43e-041646214
GeneFamilyImmunoglobulin like domain containing

OSCAR SDK1 IGDCC4 PTK7

1.45e-03193464594
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

SDK1 IGDCC4 PTK7

7.95e-03161463593
CoexpressionGSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP

KANSL3 TBXAS1 PROX2 DENND1C CCDC115 BRWD1

1.24e-05200676M6988
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRHDE MAGI2 SYNE1 CHEK2 SDK1 IGDCC4

4.36e-0719466660622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellCOVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster

AMPD2 KMT2D MAST4 PSD4 FANCA

3.89e-06159665037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410
ToppCell5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBXAS1 AMPD2 SIGLEC9 OSCAR LILRA5

7.50e-061826651fb9bdf2e9f0a9c230f109b471672f9c31e27c82
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBXAS1 AMPD2 SIGLEC9 OSCAR LILRA5

8.12e-06185665f8de11dd53b34d36368a2082f24ec1416cb7dbae
ToppCellFetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TBXAS1 AMPD2 SIGLEC9 OSCAR LILRA5

9.24e-06190665ad297172a74a80ed5c10f921e15efd1da0fd2d6b
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRHDE MAGI2 SDK1 IGDCC4 PTK7

9.72e-06192665deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

TRHDE SYNE1 CHEK2 SDK1 PTK7

1.18e-052006659b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCellE16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass

MAGI2 PCDHGA10 SCRIB SDK1

4.05e-051296645e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3
ToppCellHippocampus-Hematopoietic|Hippocampus / BrainAtlas - Mouse McCarroll V32

TBXAS1 DENND1C LILRA5 PSD4

7.47e-0515166481b2189afd72658f7e2539b856ba79cd49340215
ToppCellFrontal_cortex-Hematopoietic|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

TBXAS1 DENND1C LILRA5 PSD4

9.35e-0516066470ffbe61cfd729519b23569a43d929b117ab8d5e
ToppCell3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

VGF SIGLEC9 OSCAR LILRA5

9.58e-051616643a5f2877e3b29463a3a6da05009b0ab8747b4c47
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TRHDE KANSL3 CTDP1 BRWD1

9.58e-051616645fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCellTCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9

FBXO10 ANGEL1 IGDCC4 PTK7

1.15e-041696640a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156
ToppCell5'-Adult-Appendix-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBXAS1 AMPD2 SIGLEC9 LILRA5

1.18e-041706641c3c03821c90d41de92fef3278f71093a7fd709c
ToppCelldroplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RC3H1 CHEK2 DENND1C PSD4

1.18e-041706646210ee3bf29059e6149c047bb7e02c5f59441519
ToppCellcontrol-Myeloid-Monocyte-derived_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

TBXAS1 AMPD2 OSCAR LILRA5

1.21e-04171664e828b684744a4fdf6b63ec033c4f000b39ca0d51
ToppCell5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWA5B2 VGF AP3B2 AMER3

1.26e-041736649a3500b06d00d1d4ee42910a3a73327b21beab52
ToppCell5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWA5B2 VGF AP3B2 AMER3

1.29e-041746649f114e61458659005b6d0b4aa30a7a059e7aa5c6
ToppCellNS-control-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

TBXAS1 AMPD2 OSCAR LILRA5

1.29e-04174664758984730cd1c3ccf6866a3a8f03d6e002f3edb6
ToppCell3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWA5B2 VGF AP3B2 AMER3

1.29e-04174664a62531ebf16b32b249168dca11b870f63a8aa81c
ToppCell5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWA5B2 VGF AP3B2 AMER3

1.32e-04175664182e45f5c02214d6b9f317ff5dc43af8b42de978
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRHDE MAGI2 COL26A1 SYNE1

1.35e-04176664327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRHDE MAGI2 COL26A1 SYNE1

1.38e-04177664da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWA5B2 VGF MAGI2 AP3B2

1.41e-0417866430ca37f70d267cc9b40ca3e211f16d30360c3e6b
ToppCell3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBXAS1 OSCAR DENND1C LILRA5

1.44e-04179664ce95b601bf17ae8167d382a105384b9e65e9407f
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRHDE MAGI2 SDK1 IGDCC4

1.47e-0418066408ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TBXAS1 SIGLEC9 OSCAR LILRA5

1.50e-041816648657d35cd3dff6c89d0fde67d7e7e81e1d6c8884
ToppCellwk_08-11-Hematologic-Myeloid-APOE+_Mac2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

TBXAS1 SIGLEC9 OSCAR LILRA5

1.63e-041856648f843badc0e26cb7300c83db56c7974beb90fcf3
ToppCellfacs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

VWA5B2 VGF MAGI2 AP3B2

1.63e-041856642a8104f610fa5ce618f8105521616722462a0d42
ToppCell15-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class

VWA5B2 VGF AP3B2 AMER3

1.70e-04187664a7d2f30fe0f19e63d44603ece9890acd11b45e52
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TBXAS1 SIGLEC9 OSCAR LILRA5

1.74e-041886644e27ada1bda88811b73376c8a6136cbfc83bfdb9
ToppCell3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

VGF CLCNKA CLCNKB AMER3

1.74e-041886641f912ea015f50570e848259d948a0ba682d64bb4
ToppCellcontrol-Myeloid-Resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

TBXAS1 SIGLEC9 OSCAR LILRA5

1.74e-041886649bcd6a83da912d136745d1abcb34b3735141048c
ToppCellNS-control-d_0-4-Myeloid-Resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

TBXAS1 SIGLEC9 OSCAR LILRA5

1.81e-041906645215d2a4ac0475c621f6e6c477916149e2f73d64
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRHDE CHEK2 SDK1 PTK7

1.81e-04190664d60395739458d7f47a3350ade751fe3819500320
ToppCellwk_08-11-Hematologic-Myeloid-DC2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

TBXAS1 SIGLEC9 OSCAR LILRA5

1.81e-04190664902afe2121593ae08d083c2cea2d1ba9f848574a
ToppCellwk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

VWA5B2 C3orf22 CLCNKA AMER3

1.81e-04190664b5c6f3248c0c2f648e1578457c6a729ca22bf0da
ToppCell5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBXAS1 SIGLEC9 OSCAR LILRA5

1.85e-041916641e668d67bc254ea15518e2c7a029a61087609b7a
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRHDE CHEK2 SDK1 IGDCC4

1.88e-04192664dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VGF AP3B2 AMER3 CNGB1

1.88e-04192664307d64ef7add6a2778733e9945a1bd687feb6f44
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBXAS1 SIGLEC9 OSCAR LILRA5

1.88e-0419266462eac1b8aed4fb924946b58c0237313f697a0136
ToppCellPCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

AMPD3 SIGLEC9 OSCAR LILRA5

1.88e-04192664aa65557b35d3eba9f24b970849255d05174d1c05
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MAST4 RC3H1 BRWD1 FANCA

1.88e-04192664d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

MAGI2 MAST4 MAPK8 SDK1

1.88e-04192664e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellwk_20-22-Hematologic-Myeloid-DC3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

TBXAS1 SIGLEC9 OSCAR LILRA5

1.92e-0419366412d1e7ed0bcd1259d6dc8ae962aad69586e5d26b
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRHDE MAGI2 SYNE1 SDK1

1.96e-041946646e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TRHDE MAGI2 SDK1 IGDCC4

1.96e-0419466489b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TBXAS1 SIGLEC9 OSCAR LILRA5

1.96e-04194664badefcec2af86cbcd97305f4843e84db0f3ebc66
ToppCell21-Trachea-Immune-Hematopoietic,_Macrophage|Trachea / Age, Tissue, Lineage and Cell class

TBXAS1 SIGLEC9 OSCAR LILRA5

1.96e-041946643c4ac5f91b10802990b84db3406f5e71f8ee8b74
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TBXAS1 SIGLEC9 OSCAR LILRA5

2.00e-041956641d58585557bf8e9ce4d514e128d3a902b526331d
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TBXAS1 OSCAR LILRA5 LACTB

2.00e-041956643a30479857fc2805df92655c9599389559b1995d
ToppCellNS-moderate-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ANXA2R OSCAR LILRA5 LACTB

2.00e-04195664d87c83d2d421c9291d0a10bc9db850e9fb337667
ToppCell15-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class

TBXAS1 SIGLEC9 OSCAR LILRA5

2.00e-04195664705aa5442c61d5fdc0aafb2ad40b8c9d2dc566c6
ToppCellmoderate-Myeloid-Monocyte-derived_Macrophage|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ANXA2R OSCAR LILRA5 LACTB

2.00e-041956649c9634906168239cf978adb398787692437bf9e7
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TBXAS1 SIGLEC9 OSCAR LILRA5

2.00e-0419566410ce1b6961f10372d1f65388cbf3626a5fcd6840
ToppCellwk_15-18-Hematologic-Myeloid-DC3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

TBXAS1 SIGLEC9 OSCAR LILRA5

2.04e-0419666420808c2ce010e4fcda092ecce94487f0afff733b
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

VWA5B2 VGF CLCNKA CLCNKB

2.04e-0419666472b6a68ee760599ea86cd2d712bfd17b7b4ee417
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))|Hippocampus / BrainAtlas - Mouse McCarroll V32

CLCNKB SPEM1 PSD4

2.04e-04776639a29879348b32b6c2302820f75fd55efba39aae8
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4|Hippocampus / BrainAtlas - Mouse McCarroll V32

CLCNKB SPEM1 PSD4

2.04e-04776633763b55e5ce44b844da661e9024c9f2c847ea26f
ToppCellHippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))-|Hippocampus / BrainAtlas - Mouse McCarroll V32

CLCNKB SPEM1 PSD4

2.04e-0477663c5262a0d2040b2c580601e5a8d1ec626a0c7b560
ToppCellFetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TBXAS1 SIGLEC9 OSCAR LILRA5

2.08e-0419766448a8169a4d33c6a68d66bcd936861c75cb4b60ef
ToppCellCOVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type

TBXAS1 SIGLEC9 OSCAR LILRA5

2.08e-04197664a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCellwk_15-18-Hematologic-Myeloid-Non-cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

TBXAS1 SIGLEC9 OSCAR LILRA5

2.08e-04197664b843e9d664f909c1c12d72b93bd2b3279ca12a59
ToppCellNS-moderate-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

TBXAS1 SIGLEC9 OSCAR LILRA5

2.08e-04197664774a5053f43ac7d614c127ae7363d32a3a194f63
ToppCellCOVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type

TBXAS1 SIGLEC9 OSCAR LILRA5

2.12e-04198664ea34096bee852a7e996f097fa279381afa8f86ff
ToppCellcellseq2-Immune-Immune_Myeloid-iMON-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TBXAS1 SIGLEC9 OSCAR LILRA5

2.12e-04198664a6aa113f0af4d25c032f440c3134fe4d88ca5055
ToppCellcellseq2-Immune-Immune_Myeloid-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TBXAS1 SIGLEC9 OSCAR LILRA5

2.12e-04198664a0ceed8689d42be6b9cde89d6c182d10b3fb14fc
ToppCellPBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

TBXAS1 OSCAR LILRA5 LACTB

2.16e-0419966402256d86541be6851634283047fdc05fdf095114
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TBXAS1 OSCAR LILRA5 LACTB

2.16e-0419966496dfbcf5261286f17d9718b04ebb7b288d229b52
ToppCellHealthy_donor-Classical_Monocyte|World / disease group, cell group and cell class (v2)

TBXAS1 OSCAR LILRA5 LACTB

2.16e-0419966445e9099a13becb1e235435ceaaffb92b82ce34ee
ToppCell5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VGF AP3B2 EPS8L1 CNGB1

2.16e-04199664646d6e84a2e70042ee5d68a045abb3fc6741fcc7
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TBXAS1 SIGLEC9 OSCAR LILRA5

2.16e-04199664a4785c1921a3de18a9190e4d674ede6a90f80004
ToppCellHealthy_donor-Classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2)

TBXAS1 OSCAR LILRA5 LACTB

2.16e-04199664af3a80dbf5e0306b80f420fd41f1aaed81fe9c46
ToppCellParenchymal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

TBXAS1 AMPD2 SIGLEC9 LILRA5

2.16e-0419966436662a76211162b1bf2d58dc819cae339f715c5f
ToppCellHealthy/Control-Classical_Monocyte|Healthy/Control / Disease group and Cell class

TBXAS1 OSCAR LILRA5 LACTB

2.16e-041996644e8c7445d32fd2b7a50524dcd52141e76850c3df
ToppCellTracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

TBXAS1 SIGLEC9 OSCAR LACTB

2.16e-04199664368e2bafae00ce8e9c6ea480f81b78f96b680acd
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

SYNE1 SDK1 IGDCC4 PTK7

2.16e-041996648b86c69aaf60feff53aa782559cfece7342a23de
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

TBXAS1 SIGLEC9 OSCAR LILRA5

2.16e-04199664697a9a58c0cdb77222700d029873355d37f6ab28
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

TBXAS1 SIGLEC9 OSCAR LILRA5

2.16e-04199664c4fc638a8dad3a9b77634e8912a9326c8a2f11f5
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TBXAS1 OSCAR LILRA5 LACTB

2.16e-0419966487d513a521dd0359f4f79b01e9e97eacb0a3c6e2
ToppCellPBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TBXAS1 OSCAR LILRA5 LACTB

2.16e-0419966427667838e065370d4536eaaf5b42ad322a714b96
ToppCellCOVID-19_Mild-Myeloid|COVID-19_Mild / Disease group, lineage and cell class

TBXAS1 OSCAR LILRA5 LACTB

2.16e-04199664d0c230c3699955a80630b63ed18c770444c5dfe5
ToppCellNeuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic

TRHDE MAGI2 AMPD3 CNGB1

2.20e-04200664f75d95376a340d467c4392b872b2a2dbdd184556
ToppCellNeuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic

TRHDE MAGI2 AMPD3 CNGB1

2.20e-0420066447791c93d03ee17c1ce17e27f075be4fc6f2590e
ToppCellNeuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic

TRHDE MAGI2 AMPD3 CNGB1

2.20e-04200664fae26560ba3b0b638b6bcf92f05330824b31d21b
ToppCellTracheal-10x5prime-Immune_Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

TBXAS1 SIGLEC9 OSCAR LILRA5

2.20e-04200664fc6aebc20ecaa67606154540a691242dc0aea867
ToppCellControl_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

TRHDE SYNE1 CHEK2 PTK7

2.20e-0420066464ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCellCOVID-19-COVID-19_Mild-Myeloid|COVID-19_Mild / Disease, condition lineage and cell class

TBXAS1 OSCAR LILRA5 LACTB

2.20e-04200664247040492b3c327f4144fc94cf210dc04eecc7b0
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TBXAS1 AMPD2 SIGLEC9 LILRA5

2.20e-0420066447abc2ebf5d6575af59aa044b584acf63a463bbb
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type

TRHDE SYNE1 CHEK2 PTK7

2.20e-04200664a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCellBiopsy_Control_(H.)-Immune-Monocytes|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

TBXAS1 AMPD2 SIGLEC9 LILRA5

2.20e-04200664c58a5dc0a0d74a21ca15ee8b7a0197de32afa045
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type.

VWA5B2 TRHDE PCDHGA10 CNGB1

2.20e-04200664fe772d98c461c973dfc082e1fc50117c27ced804
ToppCellTracheal-10x3prime_v2-Immune_Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

TBXAS1 SIGLEC9 OSCAR LILRA5

2.20e-04200664cc3cdfc4636d8892500ce60518c5ccc100b9e5df
Drugneplanocin

AMPD2 AMPD3 SYNE1

6.22e-0613653CID005289040
DrugFlumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A

VGF AMPD3 PCDHGA10 EPS8L1 LILRA5 PSD4

2.04e-051966563410_UP
DrugProtoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A

PPP2R5B PCDHGA10 CTDP1 TEX13A LILRA5 FANCA

2.04e-051966562800_UP
DrugAbbott-40557

AMPD2 AMPD3

2.40e-053652CID000161884
DrugC-d4G

AMPD2 AMPD3

2.40e-053652CID000461321
DrugAC1LAJJO

AMPD2 AMPD3

2.40e-053652CID000469587
DrugAC1LANXR

AMPD2 AMPD3

2.40e-053652CID000471863
DrugNSC 326408

SYNE1 MAPK8

4.80e-054652CID000115092
Drug2'-deoxycoformycin-5'-phosphate

AMPD2 AMPD3

4.80e-054652CID000188258
Druginosine 5'-phosphosulfate

AMPD2 AMPD3

4.80e-054652CID003082299
Drug2',3'-Dideoxyadenylosuccinate

AMPD2 AMPD3

4.80e-054652CID000126574
DiseaseBartter disease type 4B

CLCNKA CLCNKB

4.20e-062612cv:C4310805
DiseaseBARTTER SYNDROME, TYPE 4B

CLCNKA CLCNKB

4.20e-062612C2751312
DiseaseBARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS

CLCNKA CLCNKB

4.20e-062612C4310805
DiseaseBartter disease type 3 (implicated_via_orthology)

CLCNKA CLCNKB

4.20e-062612DOID:0110144 (implicated_via_orthology)
DiseaseBartter disease type 4b (is_implicated_in)

CLCNKA CLCNKB

4.20e-062612DOID:0110146 (is_implicated_in)
DiseaseBARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS

CLCNKA CLCNKB

4.20e-062612613090
DiseaseBartter disease (implicated_via_orthology)

CLCNKA CLCNKB

4.20e-062612DOID:445 (implicated_via_orthology)
Diseasepontocerebellar hypoplasia (implicated_via_orthology)

AMPD2 AMPD3

4.19e-055612DOID:0060264 (implicated_via_orthology)
DiseaseBartter syndrome

CLCNKA CLCNKB

6.27e-056612cv:C0004775
Diseasenephrogenic diabetes insipidus (implicated_via_orthology)

CLCNKA CLCNKB

1.87e-0410612DOID:12387 (implicated_via_orthology)
Diseasevision disorder

MAGI2 SDK1

4.95e-0416612MONDO_0021084
DiseaseAdenocarcinoma of prostate

CHEK2 FANCA

7.80e-0420612C0007112
DiseaseSevere Congenital Microcephaly

PNKP ZC4H2

1.88e-0331612C3853041
Diseasecoffee consumption

PROX2 FANCA

2.00e-0332612EFO_0004330

Protein segments in the cluster

PeptideGeneStartEntry
SAQPPSEEEREPWEP

TRHDE

121

Q9UKU6
PEEDEPNLEPSWPHL

PPP2R5B

151

Q15173
SSNEQPPAAWPPRQD

AMER3

686

Q8N944
PDERDIWPPAQAPTS

CTDP1

401

Q9Y5B0
EPPEQAEPEPTEAWK

EPB41

601

P11171
PEPESSEAPQDPLNW

CCDC115

111

Q96NT0
PEEPENEDFHPSWSP

CSRNP2

491

Q9H175
PAPSQALQEPAPWSA

DUX4L4

351

P0CJ87
RHPNWPNQPDVEPES

FBXO10

56

Q9UK96
PPEDPDEDSDSPEWV

APBA3

141

O96018
ESPLPEAWVEEDNPP

AMPD2

641

Q01433
EDQEPEEPTPAPWAR

CHEK2

81

O96017
QENPTPWLSTAPTEP

DENND1C

696

Q8IV53
RAWDSAEVAPEPQPP

ANXA2R

11

Q3ZCQ2
EPDPEPLQPWEVTND

C3orf22

36

Q8N5N4
SPNPDVWTSEQNPPY

AMPD3

541

Q01432
LPDWPEEAPDPSVRN

AP3B2

641

Q13367
PQDWSPPPSDVEDRA

IGDCC4

1026

Q8TDY8
SPDAPPPTWEQLENG

RC3H1

366

Q5TC82
EGSPEPWDTQNPLEP

LILRA5

81

A6NI73
QVPEYDEPAPWSSPA

MAGI2

1231

Q86UL8
EPPQEQSLAPWSPQT

LACTB

81

P83111
INVWYDPSEAEAPPP

MAPK8

321

P45983
EDTPLVPQAPPNTDW

PCDHGA10

806

Q9Y5H3
PPPGANEEIPDDFDW

FOXJ2

556

Q9P0K8
QPLLPQTQDSWDPAP

OSCAR

261

Q8IYS5
PPELDRDSPFPWSQV

PROX2

31

Q3B8N5
PIPEPEWPAQTAQLD

C4orf50

176

Q6ZRC1
IEDQPPPWQPENCWE

CEFIP

1011

Q711Q0
PELLPEEPNQASPWA

CEFIP

1086

Q711Q0
LSPEAASPAPNPDWL

FANCA

1211

O15360
LSPWDMEPIPDNVDP

BRWD1

1116

Q9NSI6
NWPEKDEAPPPDAQD

MAST4

801

O15021
RTDADAPPPPEDWEE

KANSL3

111

Q9P2N6
APPPPEDWEEHVNRT

KANSL3

116

Q9P2N6
QPSNLDLPPAPELDW

CENATAC

201

Q86UT8
PNQEWLSSSPPATPD

FHIP2A

541

Q5W0V3
PPVTDPQSRAWEDPV

EPS8L1

426

Q8TE68
SQLEVTWDPPPPESQ

SDK1

1716

Q7Z5N4
LPAPESTPPTWNEDF

COL26A1

166

Q96A83
PTTPWQEDPEPEDEN

NDUFB11

51

Q9NX14
PEDETWEVLEEAPPP

IRGQ

416

Q8WZA9
PPPEPTWEEQQTSVL

PDIA5

386

Q14554
EVKQPQEEDWTPPDP

NUTM2A

546

Q8IVF1
PAPAPARDELPDWNE

VGF

511

O15240
WLSAVQPDLEPSPQP

SYNE1

4051

Q8NF91
WQEPSSQEPPPDGTR

SCYL1

706

Q96KG9
PSEEWPNPPTLQEAG

FAF2

416

Q96CS3
DPPEPFEEQTWATDP

PSD4

41

Q8NDX1
QGPLTEPWAEDSPPD

SIGLEC9

401

Q9Y336
DSSPQLWPEPDFRNP

TFB2M

46

Q9H5Q4
WEETRTPESQPDTPP

PNKP

106

Q96T60
EEQEDEQPPWASPSP

SCRIB

1426

Q14160
TPEAPEPPSQEQWAI

SKIV2L

271

Q15477
PWSQDAPESPPQTIR

SPEM1

166

Q8N4L4
APEPVPQEEASIWPF

ANGEL1

186

Q9UNK9
TQNSSPPWPEELDPQ

CLCNKA

371

P51800
PQPPKSSEVWRDEPA

CNGB1

171

Q14028
TQNSSPPWPEELDPQ

CLCNKB

371

P51801
DPEHWPSPETFNPER

TBXAS1

441

P24557
PVADNVLSTAPPWPD

SAGE1

91

Q9NXZ1
QPAPDNVLSTAPPWL

SAGE2P

131

A6NJ88
LPPPQQPQAEDEDDW

WASH4P

461

A8MWX3
PSEEPATSPWPAEQS

SPPL2B

536

Q8TCT7
DVPQEPVPTLWNEPA

SNORC

26

Q6UX34
PVATPVPPEEQANLW

SMO

641

Q99835
QPPSPPVREAAWDQA

VWA5B2

871

Q8N398
APVPPQLPSDWEAFD

TEX13A

326

Q9BXU3
QPPPSLQWLFEDETP

PTK7

251

Q13308
PPPQQPQAEEDEDDW

WASH6P

431

Q9NQA3
EWQTEPQEPPIPESL

ZC4H2

141

Q9NQZ6
PWDPPDNLAETQKPE

KMT2D

4376

O14686